Lyra Therapeutics Share Price (NASDAQ: LYRA)
$6.96
Live
Last updated on
Check the interactive Lyra Therapeutics Stock chart to analyse performance
Lyra Therapeutics Inc Key Stats
Check Lyra Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Lyra Therapeutics Stock including INR - Dollar returns
The Lyra Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Lyra Therapeutics investment value today
Current value as on today
₹46,855
Returns
Returns from Lyra Therapeutics Stock
Dollar Returns*
₹4,673 (+4.67%)
Indian investors sentiment towards Lyra Therapeutics Stock
Global Institutional Holdings in Lyra Therapeutics Inc
Name
Holdings %
Perceptive Advisors LLC
15.70%
BlackRock Inc
3.71%
Vanguard Group Inc
1.80%
Ikarian Capital, LLC
1.30%
Geode Capital Management, LLC
1.25%
ADAR1 Capital Management LLC
0.66%
Analyst Recommendation on Lyra Therapeutics Stock
Buy
91%Buy
8%Hold
0%Sell
Based on 12 Wall street analysts offering stock ratings for Lyra Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Lyra Therapeutics Share Price Target
What analysts predicted
Upside of 65.23%
Target:
$11.50
Current:
$6.96
Lyra Therapeutics share price target is $11.50, a slight Upside of 65.23% compared to current price of $6.96 as per analysts' prediction.
Lyra Therapeutics Stock Insights
Price Movement
In the last 7 days, LYRA stock has moved down by -4.6%Decreasing Revenue
Revenue is down for the last 3 quarters, 209.0K → 183.0K (in $), with an average decrease of 6.2% per quarterIncreasing Net Profit
Netprofit is up for the last 5 quarters, -48.13M → -7.43M (in $), with an average increase of 89.2% per quarterLYRA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.0% return, outperforming this stock by 119.1%LYRA vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.9% return, outperforming this stock by 211.3%Price to Sales
ForLYRA every $1 of sales, investors are willing to pay $12.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.7 for every $1 of sales.
Lyra Therapeutics Technicals Summary
Sell
Neutral
Buy
Lyra Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Lyra Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -11.28% | -32.55% | -58.06% | -97.64% | -98.95% |
 | 5.16% | -16.9% | -51.12% | -0.89% | -2.51% |
 | 4.54% | 18.87% | 52.28% | 84.02% | 26.72% |
 | -16.02% | -19.22% | -19.42% | 37.43% | 43.36% |
 | 38.9% | 84.99% | 60.96% | 115.82% | 243.29% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -21.0 | -2.38 | -0.3 | NA | 1.0 |
| 14.86 | 14.86 | 1.21 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.29 | -0.05 | -0.01 | NA | 34.32 |
| 27.64 | 27.64 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $12.3M | -98.95% | NA | 0.0% |
| Buy | $62.5B | -2.51% | 14.86 | 31.37% |
| NA | $38.3B | 26.72% | NA | -3.89% |
| Buy | $99.7B | 43.36% | 27.64 | 31.86% |
| Buy | $58.2B | 243.29% | NA | -12.96% |
About Lyra Therapeutics Inc
Key Management of Lyra Therapeutics Inc
Important FAQs about investing in LYRA Stock from India :
What is Lyra Therapeutics share price today?
Lyra Therapeutics share price today is $6.96 as on . Lyra Therapeutics share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.
What is the 52 week high and 52 week low for Lyra Therapeutics share?
Lyra Therapeutics share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Lyra Therapeutics stock price today i.e. is trending at $6.96, lower by 81.44% versus the 52 week high.
How to invest in Lyra Therapeutics Stock (LYRA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Lyra Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lyra Therapeutics Shares that will get you 0.2155 shares as per Lyra Therapeutics share price of $6.96 per share as on August 27, 2025 at 11:34 pm IST.
What is the minimum amount required to buy Lyra Therapeutics Stock (LYRA) from India?
Indian investors can start investing in Lyra Therapeutics (LYRA) shares with as little as ₹87.86 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Lyra Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 27, 2025).
Based on Lyra Therapeutics share’s latest price of $6.96 as on August 27, 2025 at 11:34 pm IST, you will get 1.4368 shares of Lyra Therapeutics. Learn more about
fractional shares .
What are the returns that Lyra Therapeutics has given to Indian investors in the last 5 years?
Lyra Therapeutics stock has given -98.95% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Global X Short-term Treasury Ladder Etf
$50.32
+0.12%
- Advisorshares Restaurant Etf
$28.58
+0.28%
Kura Oncology Inc$7.84
+3.43%
Citizens & Northern Corp$20.41
+0.05%
- Vanguard 3m Tresury Bill Etf
$75.58
+0.03%
United States Gasoline Fund Lp$63.45
+0.0%
- Fidelity Clean Energy Etf
$17.77
-0.73%
Spdr S&p 500 Fossil Fuel Reserves Free Etf$53.21
+0.21%
- Spdr Ssga Us Eq Prem Inc Etf
$30.91
-0.1%